(Q43954053)

28 November 2017

title

Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties (English)

1 reference

28 November 2017

author name string

Frederick W Holtsberg

1

1 reference

28 November 2017

Charles Mark Ensor

2

1 reference

28 November 2017

Marion R Steiner

3

1 reference

28 November 2017

John S Bomalaski

4

1 reference

28 November 2017

Mike A Clark

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Journal of Controlled Release

28 November 2017

published in

1 reference

28 November 2017

volume

80

1 reference

28 November 2017

issue

1-3

1 reference

28 November 2017

page(s)

259-271

1 reference

Use of ?-asparaginase in childhood ALL

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Anti‐tumor Activity of Arginine Deiminase from Mycoplasma arginini and Its Growth‐inhibitory Mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Chemical modification by polyethylene glycol of the anti-tumor enzyme arginine deiminase from Mycoplasma arginini

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Development of pegylated interferons for the treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Chemical modification of silk fibroin with cyanuric chloride-activated poly(ethylene glycol): analyses of reaction site by 1H-NMR spectroscopy and conformation of the conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant Conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Nucleotide sequence of the arginine deiminase gene of Mycoplasma hominis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

High-level expression of Mycoplasma arginine deiminase in Escherichia coli and its efficient renaturation as an anti-tumor enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Pegylation: a novel process for modifying pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Acute neonatal and benign citrullinaemia in one sibship

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Intrafamilial phenotypic variability in citrullinaemia: report of a family

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

Preparation of recombinant argininosuccinate synthetase and argininosuccinate lyase: expression of the enzymes in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0168-3659%2802%2900042-1

7 January 2021

10.1016/S0168-3659(02)00042-1

Identifiers

DOI

1 reference

28 November 2017

1 reference